[Trained immunity : emerging strategies against antibiotic resistance].

Auteurs Badin L, Franc C, Gilbert P, Magdeleine JJ, Martin L, Vernaz R, Arrighi N, Garcia-Sanchez JA

Medecine sciences : M/S Mar 2024

[PROTAC technology: a promising approach in oncology].

Auteurs Azuaga Moreso M, Bertrand C, Duffrene J, Dumont M, Lecouffe A, Muller C, Arrighi N, Onesto C

Medecine sciences : M/S Mar 2024

[When ubiquitination intertwines with cutaneous melanoma: a mechanism to explore].

Auteurs Arrighi N, Breda L, Kerdilès T, Meyer C, Prugneau L, Rabatel O, Wagner G, Krossa I, Pisibon C

Medecine sciences : M/S Mar 2024

Improving nutritional status after allogeneic stem cell transplantation: results of phase 2 ALLONUT clinical trial.

Auteurs Estran S, Loschi M, Benachour S, Soldati A, Chiche E, Sammut R, Robert G, Jacquel A, Chibois J, Schneider S, Cluzeau T

Bone marrow transplantation Mar 2024

Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.

Auteurs Montemagno C, Jacquel A, Pandiani C, Rastoin O, Dawaliby R, Schmitt T, Bourgoin M, Palenzuela H, Rossi AL, Ambrosetti D, Durivault J, Luciano F, Borchiellini D, Le Du J, Gonçalves LCP, Auberger P, Benhida R, Kinget L, Beuselinck B, Ronco C, Pagès G, Dufies M

Journal of experimental & clinical cancer research : CR Mar 2024

Mechanisms of melanoma aggressiveness with age.

Auteurs Bertolotto C

Nature aging Mar 2024

Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.

Auteurs Krug A, Tosolini M, Madji Hounoum B, Fournié JJ, Geiger R, Pecoraro M, Emond P, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E

Journal of experimental & clinical cancer research : CR Feb 2024

Roles of innate lymphoid cells in metabolic and alcohol-associated liver diseases.

Auteurs Bourinet M, Anty R, Gual P, Luci C

JHEP reports : innovation in hepatology Feb 2024

Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759.

Auteurs Pujalte-Martin M, Belaïd A, Bost S, Kahi M, Peraldi P, Rouleau M, Mazure NM, Bost F

Molecular oncology Jan 2024

Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening.

Auteurs Grytsai O, Hamouda-Tekaya N, Botton T, Rocchi S, Benhida R, Ronco C

ChemMedChem Dec 2023